The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories.
The main treatment modalities for overweight and obese individuals remain dieting and physical exercise.
The global Anti-obesity Drugs market size is expected to reach US$ 5569.5 million by 2029, growing at a CAGR of 17.0% from 2023 to 2029. The market is mainly driven by the significant applications of Anti-obesity Drugs in various end use industries. The expanding demands from the Kids and Adults, are propelling Anti-obesity Drugs market. Peripherally Acting Anti-obesity Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Centrally Acting Anti-obesity Drugs segment is estimated at % CAGR for the next seven-year period.
The report analysts forecast the Global Anti-obesity Drugs market to grow at a CAGR of 41.45 percent over the period 2013-2022.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anti-obesity Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anti-obesity Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anti-obesity Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anti-obesity Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anti-obesity Drugs covered in this report include Merck, Novo Nordisk, Pfizer, Arena Pharmaceuticals, Roche, GlaxoSmithKline, Orexigen Therapeutics, Vivus and Amylin, etc.
The global Anti-obesity Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Merck
- Novo Nordisk
- Pfizer
- Arena Pharmaceuticals
- Roche
- GlaxoSmithKline
- Orexigen Therapeutics
- Vivus
- Amylin
- Alizyme
- Boehringer Ingelheim
- Eisai
Global Anti-obesity Drugs market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti-obesity Drugs market, Segment by Type:
- Peripherally Acting Anti-obesity Drugs
- Centrally Acting Anti-obesity Drugs
Global Anti-obesity Drugs market, by Application:
- Kids
- Adults
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Anti-obesity Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Anti-obesity Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Anti-obesity Drugs Market Overview
1.1 Anti-obesity Drugs Product Overview
1.2 Anti-obesity Drugs Market Segment by Type
1.2.1 Peripherally Acting Anti-obesity Drugs
1.2.2 Centrally Acting Anti-obesity Drugs
1.3 Global Anti-obesity Drugs Market Size by Type
1.3.1 Global Anti-obesity Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Anti-obesity Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Anti-obesity Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-obesity Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Anti-obesity Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Anti-obesity Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Anti-obesity Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Anti-obesity Drugs Sales Breakdown by Type (2018-2023)
2 Global Anti-obesity Drugs Market Competition by Company
2.1 Global Top Players by Anti-obesity Drugs Sales (2018-2023)
2.2 Global Top Players by Anti-obesity Drugs Revenue (2018-2023)
2.3 Global Top Players by Anti-obesity Drugs Price (2018-2023)
2.4 Global Top Manufacturers Anti-obesity Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-obesity Drugs Market Competitive Situation and Trends
2.5.1 Anti-obesity Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-obesity Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-obesity Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-obesity Drugs Market
2.8 Key Manufacturers Anti-obesity Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-obesity Drugs Status and Outlook by Region
3.1 Global Anti-obesity Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Anti-obesity Drugs Historic Market Size by Region
3.2.1 Global Anti-obesity Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Anti-obesity Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Anti-obesity Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Anti-obesity Drugs Forecasted Market Size by Region
3.3.1 Global Anti-obesity Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Anti-obesity Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Anti-obesity Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Anti-obesity Drugs by Application
4.1 Anti-obesity Drugs Market Segment by Application
4.1.1 Kids
4.1.2 Adults
4.2 Global Anti-obesity Drugs Market Size by Application
4.2.1 Global Anti-obesity Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Anti-obesity Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Anti-obesity Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-obesity Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Anti-obesity Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Anti-obesity Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Anti-obesity Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Anti-obesity Drugs Sales Breakdown by Application (2018-2023)
5 North America Anti-obesity Drugs by Country
5.1 North America Anti-obesity Drugs Historic Market Size by Country
5.1.1 North America Anti-obesity Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Anti-obesity Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Anti-obesity Drugs Sales in Value by Country (2018-2023)
5.2 North America Anti-obesity Drugs Forecasted Market Size by Country
5.2.1 North America Anti-obesity Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Anti-obesity Drugs Sales in Value by Country (2024-2029)
6 Europe Anti-obesity Drugs by Country
6.1 Europe Anti-obesity Drugs Historic Market Size by Country
6.1.1 Europe Anti-obesity Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Anti-obesity Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Anti-obesity Drugs Sales in Value by Country (2018-2023)
6.2 Europe Anti-obesity Drugs Forecasted Market Size by Country
6.2.1 Europe Anti-obesity Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Anti-obesity Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Anti-obesity Drugs by Region
7.1 Asia-Pacific Anti-obesity Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Anti-obesity Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Anti-obesity Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Anti-obesity Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Anti-obesity Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-obesity Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Anti-obesity Drugs Sales in Value by Region (2024-2029)
8 Latin America Anti-obesity Drugs by Country
8.1 Latin America Anti-obesity Drugs Historic Market Size by Country
8.1.1 Latin America Anti-obesity Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Anti-obesity Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Anti-obesity Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Anti-obesity Drugs Forecasted Market Size by Country
8.2.1 Latin America Anti-obesity Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Anti-obesity Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Anti-obesity Drugs by Country
9.1 Middle East and Africa Anti-obesity Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Anti-obesity Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Anti-obesity Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Anti-obesity Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Anti-obesity Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-obesity Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Anti-obesity Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Anti-obesity Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Anti-obesity Drugs Products Offered
10.1.5 Merck Recent Development
10.2 Novo Nordisk
10.2.1 Novo Nordisk Company Information
10.2.2 Novo Nordisk Introduction and Business Overview
10.2.3 Novo Nordisk Anti-obesity Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novo Nordisk Anti-obesity Drugs Products Offered
10.2.5 Novo Nordisk Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Anti-obesity Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Anti-obesity Drugs Products Offered
10.3.5 Pfizer Recent Development
10.4 Arena Pharmaceuticals
10.4.1 Arena Pharmaceuticals Company Information
10.4.2 Arena Pharmaceuticals Introduction and Business Overview
10.4.3 Arena Pharmaceuticals Anti-obesity Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Arena Pharmaceuticals Anti-obesity Drugs Products Offered
10.4.5 Arena Pharmaceuticals Recent Development
10.5 Roche
10.5.1 Roche Company Information
10.5.2 Roche Introduction and Business Overview
10.5.3 Roche Anti-obesity Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Roche Anti-obesity Drugs Products Offered
10.5.5 Roche Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Information
10.6.2 GlaxoSmithKline Introduction and Business Overview
10.6.3 GlaxoSmithKline Anti-obesity Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 GlaxoSmithKline Anti-obesity Drugs Products Offered
10.6.5 GlaxoSmithKline Recent Development
10.7 Orexigen Therapeutics
10.7.1 Orexigen Therapeutics Company Information
10.7.2 Orexigen Therapeutics Introduction and Business Overview
10.7.3 Orexigen Therapeutics Anti-obesity Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Orexigen Therapeutics Anti-obesity Drugs Products Offered
10.7.5 Orexigen Therapeutics Recent Development
10.8 Vivus
10.8.1 Vivus Company Information
10.8.2 Vivus Introduction and Business Overview
10.8.3 Vivus Anti-obesity Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Vivus Anti-obesity Drugs Products Offered
10.8.5 Vivus Recent Development
10.9 Amylin
10.9.1 Amylin Company Information
10.9.2 Amylin Introduction and Business Overview
10.9.3 Amylin Anti-obesity Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Amylin Anti-obesity Drugs Products Offered
10.9.5 Amylin Recent Development
10.10 Alizyme
10.10.1 Alizyme Company Information
10.10.2 Alizyme Introduction and Business Overview
10.10.3 Alizyme Anti-obesity Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Alizyme Anti-obesity Drugs Products Offered
10.10.5 Alizyme Recent Development
10.11 Boehringer Ingelheim
10.11.1 Boehringer Ingelheim Company Information
10.11.2 Boehringer Ingelheim Introduction and Business Overview
10.11.3 Boehringer Ingelheim Anti-obesity Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Boehringer Ingelheim Anti-obesity Drugs Products Offered
10.11.5 Boehringer Ingelheim Recent Development
10.12 Eisai
10.12.1 Eisai Company Information
10.12.2 Eisai Introduction and Business Overview
10.12.3 Eisai Anti-obesity Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Eisai Anti-obesity Drugs Products Offered
10.12.5 Eisai Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-obesity Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-obesity Drugs Industrial Chain Analysis
11.4 Anti-obesity Drugs Market Dynamics
11.4.1 Anti-obesity Drugs Industry Trends
11.4.2 Anti-obesity Drugs Market Drivers
11.4.3 Anti-obesity Drugs Market Challenges
11.4.4 Anti-obesity Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-obesity Drugs Distributors
12.3 Anti-obesity Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
